However, an increase in INPP4B protein expression was observed in 14–40% of breast cancers relative to normal tissue associated with ER/PR-positivity and the luminal (ER+ and/or PR+) breast cancer subtype (Fig. 1a, b and Supplementary Fig. 1b,,  c). This evidence concerns the gene INPP4B and breast carcinoma.